Eczema herpeticum is an easily missed entity most commonly seen in the pediatric population and carries the risk of systemic compromise and a 10% mortality rate. Clinicians should maintain high clinical suspicion when encountering children or young adults with a history of atopic dermatitis or other erosive dermatoses and who present with vesicular lesions, punched-out erosions, and systemic symptoms. We present 3 severe cases of eczema herpeticum that were potentially overlooked and demonstrate the need for elevated awareness to avoid potential pitfalls.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/PEC.0000000000000516 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Kaposi Varicelliform Eruption in a Chronic Kidney Disease Individual Under Tacrolimus: A Case Report.
Case Rep Dermatol Med
October 2024
Department of Dermatology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
"Kaposi varicelliform eruption" (KVE), also known as "eczema herpeticum," refers to a rare widespread skin infection. The primary causal agent is thought to be the herpes simplex virus (HSV). Though common in patients with underlying skin dermatosis, systemic immunosuppression can at times lead to KVE.
View Article and Find Full Text PDFSevere herpes simplex virus - 1 Kaposi varicelliform eruption and SARS-CoV-2 infection in atopic dermatitis treated with dupilumab.
BMC Infect Dis
November 2024
Department of Dermatology, The First Affiliated Hospital of Chongqing College of Traditional Chinese Medicine, No. 40 Daomenkou St., District Yuzhong, Chongqing, 400011, P.R. China.
Article Synopsis
- A case report discusses a 35-year-old male with a history of atopic dermatitis who developed a severe herpes simplex virus-1 (HSV-1) related skin condition called Kaposi varicelliform eruption (KVE) after a recent SARS-CoV-2 infection.
- The patient's skin condition involved widespread vesicles and pustules that rapidly progressed over four months, and laboratory tests confirmed he was positive for HSV-1 with elevated IgE levels and decreased immune cell counts.
- Treatment with valaciclovir and other medications led to significant improvement, with the skin lesions resolving completely within a week, emphasizing the risk of severe viral eruptions in patients with existing skin conditions following viral infections.
[Erythroderma Complicated With Kaposi Varicelliform Eruption:Report of One Case].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
October 2024
Department of Dermatology, Second Hospital of Shanxi Medical University,Taiyuan 030001,China.
Kaposi varicelliform eruption (KVE) refers to an infectious skin disease that occurs after infection with herpes simplex virus,Coxsackie virus,or other viruses on the basis of preexisting skin diseases,commonly observed in the patients with eczema.It is rare for the patients with erythroderma to be complicated with KVE,and symptoms are often atypical,which pose a challenge to the diagnosis and treatment.This article reports a case of erythroderma complicated with KVE,aiming to raise awareness of clinicians in treating this disease.
View Article and Find Full Text PDFEfficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up).
Br J Dermatol
December 2024
Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg, Germany.
Article Synopsis
- * The study compared the effectiveness and safety of upadacitinib (UPA) and dupilumab (DUPI) in adolescents and adults with moderate-to-severe AD over 16 weeks, with UPA showing better results in reducing skin severity and itching.
- * UPA was found to be significantly more effective than DUPI in achieving the treatment goals, with no new safety concerns reported during the study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!